drugset

drugset / Trial / NCT00237393

Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)

NCT00237393 ↗

Phase 4 Completed 80 enrolled Ralph H. Johnson VA Medical Center AstraZeneca · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to determine if quetiapine is effective in the treatment of PTSD.

Timeline

Start: 2003-08
Primary completion: —
Completion: 2007-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Quetiapine	Small molecule	400 mg	—

Indications